benign%20prostatic%20hyperplasia
BENIGN PROSTATIC HYPERPLASIA
Benign prostatic hyperplasia (BPH) is a histopathological diagnosis characterized by epithelial cell & smooth muscle cell proliferation in the transition zone of the prostate leading to a non-malignant enlargement of the gland, which may result in lower urinary tract symptoms, including voiding and storage symptoms.
It is commonly called enlarged prostate.
Etiology is unknown but due to its similarity to the embryonic morphogenesis of the prostate has led to the hypothesis that BPH may be the result of "reawakening" in adulthood of embryonic induction processes.

Lifestyle Modification

  • Reduce intake of liquids, particularly before going out in public or before periods of sleep
  • Avoid or reduce intake of caffeinated or alcoholic beverages
  • Avoid or monitor use of medications such as decongestants, antihistamines, antidepressants, & diuretics
  • Train the bladder to hold more urine for longer periods
  • Exercise pelvic floor muscles (Kegel exercise)
  • Prevent or treat constipation
  • Try to urinate at least once every 3 hours
  • “Double voiding” may help - after urinating, wait, & try to urinate again
  • Try to achieve & maintain a healthy weight
Editor's Recommendations
Most Read Articles
Tristan Manalac, 5 days ago
Gestational exposure to grain products fortified with folic acid appears to be linked to a lower risk of psychosis in offspring, according to a recent study.
Pearl Toh, 5 days ago
A dual-hormone artificial pancreas (DAP) with a rapid delivery of insulin and pramlintide in a fixed ratio improves glycaemic control and reduces glucose variability in adults with type 1 diabetes (T1D) compared with first-generation artificial pancreas delivering insulin alone, according to a study presented at ADA 2018.
2 days ago
Chocolate consumption is not associated with risk of coronary heart disease (CHD), stroke or both combined in postmenopausal women free of pre-existing major chronic disease, a study suggests.
Pearl Toh, 2 days ago
More intensive lowering of LDL-C levels was associated with a progressively greater survival benefit than less intensive approach, when the baseline LDL-C levels were ≥100 mg/dL, reveals a meta-analysis of 34 randomized trials.